Effects of Thiamine on Cardiac Function in Patients With Systolic Heart Failure: Systematic Review and Metaanalysis of Randomized, Double-Blind, Placebo-Controlled Trials

REFERENCES

1. ↵
   1. American Heart Association

   (2005) (2005) Heart Disease and Stroke Statistics —(American Heart Association, Dallas, TX) Update.
2. ↵
   1. Bonow RO,
   2. Bennett S,
   3. Casey DE Jr.,
   4. et al.

   (9 20, 2005) American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures); Heart Failure Society of America. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 46(6):1144–1178, pmid:16168305.

   OpenUrlFREE Full Text
3. ↵
   1. Massie BM,
   2. Shah NB

   (6, 1997) Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 133(6):703–712, pmid:9200399.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Yui Y,
   2. Itokawa Y,
   3. Kawai C

   (9, 1980) Furosemide-induced thiamine deficiency. Cardiovasc Res 14(9):537–540, pmid:7214397.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Seligmann H,
   2. Halkin H,
   3. Rauchfleisch S,
   4. et al.

   (8, 1991) Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 91(2):151–155, pmid:1867241.

   OpenUrlCrossRefPubMedWeb of Science
6. 1. Brady JA,
   2. Rock CL,
   3. Horneffer MR

   (5, 1995) Thiamin status, diuretic medications, and the management of congestive heart failure. J Am Diet Assoc 95(5):541–544, pmid:7722187.

   OpenUrlCrossRefPubMedWeb of Science
7. 1. Hanninen SA,
   2. Darling PB,
   3. Sole MJ,
   4. Barr A,
   5. Keith ME

   (1 17, 2006) The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 47(2):354–361, pmid:16412860.

   OpenUrlFREE Full Text
8. ↵
   1. Zenuk C,
   2. Healey J,
   3. Donnelly J,
   4. Vaillancourt R,
   5. Almalki Y,
   6. Smith S

   (Winter 2003) Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. Can J Clin Pharmacol 10(4):184–188, pmid:14712323.

   OpenUrlPubMed
9. ↵
   1. Shimon I,
   2. Almog S,
   3. Vered Z,
   4. et al.

   (5, 1995) Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 98(5):485–490, pmid:7733128.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Liberati A,
    2. Altman DG,
    3. Tetzlaff J,
    4. et al.

    (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, Jul 21;339:b2700.
11. ↵
    1. Schoenenberger AW,
    2. Schoenenberger-Berzins R,
    3. der Maur CA,
    4. Suter PM,
    5. Vergopoulos A,
    6. Erne P

    (3, 2012) Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol 101(3):159–164, pmid:22057652, Epub 2011 Nov 5.

    OpenUrlCrossRefPubMed
12. ↵
    1. Higgins JP,
    2. Thompson SG

    (6 15, 2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558, pmid:12111919.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Higgins JPT,
    2. Green S

    (2, 2008]) (2008) Cochrane Handbook for Systematic Reviews of Interventions (John Wiley & Sons Inc, Hoboken, NJ) Version 5.0.0 [updated, The Cochrane Collaboration.
14. ↵
    1. Bakker SJ,
    2. Leunissen KM

    (9, 1995) Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilatation in cardiovascular beriberi. Med Hypotheses 45(3):265–267, pmid:8569549.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Cintron G,
    2. Johnson G,
    3. Francis G,
    4. Cobb F,
    5. Cohn JN

    (6, 1993) Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87((6 Suppl)):VI17–VI123, pmid:8500235.

    OpenUrlPubMed
16. ↵
    1. Jessup M,
    2. Abraham WT,
    3. Casey DE,
    4. et al.

    (2009) (2009) focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016, pmid:19324967, Apr 14; Epub 2009 Mar 26.

    OpenUrlFREE Full Text
17. ↵
    1. Krim SR,
    2. Campbell P,
    3. Lavie CJ,
    4. Ventura H

    (3, 2013) Micronutrients in chronic heart failure. Curr Heart Fail Rep 10(1):46–53, pmid:23070580.

    OpenUrlCrossRefPubMed
18. ↵
    1. Wooley JA

    (Oct-Nov 2008) Characteristics of thiamin and its relevance to the management of heart failure. Nutr Clin Pract 23(5):487–493, pmid:18849553.

    OpenUrlCrossRefPubMed
19. ↵
    1. Dinicolantonio JJ,
    2. Niazi AK,
    3. Lavie CJ,
    4. O'Keefe JH,
    5. Ventura HO

    (7, 2013) Thiamine supplementation for the treatment of heart failure: a review of the literature. Congest Heart Fail 19(4):214–222, pmid:23910704.

    OpenUrlPubMed